Targeted therapy in rheumatoid arthritis.
Köller, Marcus D
Targeted therapy in rheumatoid arthritis. [electronic resource] - Wiener medizinische Wochenschrift (1946) Jan 2006 - 53-60 p. digital
Publication Type: Journal Article; Review
0043-5341
10.1007/s10354-005-0245-6 doi
Abatacept
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--drug therapy
B-Lymphocytes--drug effects
Clinical Trials as Topic
Drug Delivery Systems--methods
Immunoconjugates--therapeutic use
Interleukin-1--antagonists & inhibitors
Interleukin-2--antagonists & inhibitors
Receptors, Interleukin-6--antagonists & inhibitors
Rituximab
Signal Transduction--drug effects
Synovitis--drug therapy
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Targeted therapy in rheumatoid arthritis. [electronic resource] - Wiener medizinische Wochenschrift (1946) Jan 2006 - 53-60 p. digital
Publication Type: Journal Article; Review
0043-5341
10.1007/s10354-005-0245-6 doi
Abatacept
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Antirheumatic Agents--therapeutic use
Arthritis, Rheumatoid--drug therapy
B-Lymphocytes--drug effects
Clinical Trials as Topic
Drug Delivery Systems--methods
Immunoconjugates--therapeutic use
Interleukin-1--antagonists & inhibitors
Interleukin-2--antagonists & inhibitors
Receptors, Interleukin-6--antagonists & inhibitors
Rituximab
Signal Transduction--drug effects
Synovitis--drug therapy
Tumor Necrosis Factor-alpha--antagonists & inhibitors